{
    "clinical_study": {
        "@rank": "40234", 
        "arm_group": {
            "arm_group_label": "Chronic spastic stroke patients", 
            "description": "Chronic spastic stroke patients treated regularly with botulinum toxin injection in lower limb muscles"
        }, 
        "brief_summary": {
            "textblock": "Chronic stroke patients exhibit gait pattern alterations which are mainly due to spasticity\n      and treated  with repetitive multifocal botulinum toxin injection(BTI). Several studies\n      demonstrated that single BTI-session in a single muscle of paretic lower limb(LL) improved\n      kinematic gait parameters(GP) but surprisingly none of them assessed the effects of\n      repetitive multifocal BTI on patient's gait pattern and their duration.\n\n      The aim was to evaluate the impact of repetitive multifocal BTI-sessions on GP of chronic\n      stroke patients. To that end, gait of patients has been compared using 3D-gait analysis\n      after at least 2 consecutive BTI sessions."
        }, 
        "brief_title": "Stroke's Gait Pattern Modifications of Induced by Repeated BTI", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Effect of Repeated Botulinum Toxin Injection on Gait Pattern in Stroke Patients", 
        "condition_browse": {
            "mesh_term": [
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "All the patients will be tretaed with BTI . these injections will be performed under\n      electrical stimulation control (~5mA). The dose, the number of site of injection per muscle\n      is at the discretion of the physician according to patients' needs and physicians' routine\n      clinical practice. The dilution the most commonly used will depend on the type of BoNT-A\n      (BOTOX\u00ae, XEOMIN\u00ae or DYSPORT\u00ae) and was 100 U for 2.5ml (BOTOX\u00ae and XEOMIN\u00ae) or 500 U for 2.5\n      ml (Dysport\u00ae)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        ->18 years\n\n          -  a single hemispheric cerebral vascular lesion more than 6 months previously\n\n          -  able to walk 10 meters without any assistance\n\n          -  having benefited of at least 2 consecutive BTI  sessions, second 3D gait analysis\n             performed at least 3 months after the last BTI.\n\n        Exclusion Criteria:\n\n          -  patient's refusal to participate to the study\n\n          -  Inability to read the selected text\n\n          -  Inability to cooperate\n\n          -  No affiliation to social security"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "STROKE PATIENTS"
            }
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01973023", 
            "org_study_id": "1687472"
        }, 
        "intervention": {
            "arm_group_label": "Chronic spastic stroke patients", 
            "description": "Motion analysis was used to assess the modifications of gait pattern in chronic spastic stroke patients regularly treated with botulinum toxin injection", 
            "intervention_name": "Motion analysis", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Botulinum Toxins"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "botulinum toxin injection", 
            "stroke", 
            "3D motion analysis", 
            "gait apttern"
        ], 
        "lastchanged_date": "March 11, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Garches", 
                    "country": "France", 
                    "zip": "92380"
                }, 
                "name": "Hopital Raymond Poincare"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Improvement of Chronic Stroke Patients Gait Pattern Following Repetitive Multifocal Botulinum Toxin Injection Sessions in Paretic Lower Limb: an Observational Study.", 
        "overall_official": {
            "affiliation": "HOPITAL RAYMOND POINCARE-GARCHES", 
            "last_name": "ROCHE Nicolas, MDPHD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "peak knee flexion in swing phase(\u00b0)", 
            "measure": "kinematics gait parameters", 
            "safety_issue": "No", 
            "time_frame": "3h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01973023"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre d'Investigation Clinique et Technologique 805", 
            "investigator_full_name": "Nicolas ROCHE", 
            "investigator_title": "MDPHD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "gait velocity(m/s)", 
            "measure": "spatiotemporal gait parmeters", 
            "safety_issue": "No", 
            "time_frame": "3h"
        }, 
        "source": "Centre d'Investigation Clinique et Technologique 805", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre d'Investigation Clinique et Technologique 805", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}